Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419716 · ClinicalTrials.gov registry record
A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval
A clinical trial of Colorectal Cancer and Colorectal Cancer Screening, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 2,404
- Enrollment target
- 20
- Study locations
NCT02419716 is a study of Colorectal Cancer and Colorectal Cancer Screening that has completed, run by Exact Sciences Corporation. The registered enrollment target is 2,404 participants, above the 1,505-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (60% higher). The trial reports 20 study locations across 3 states.
The verdict
NCT02419716, a study of Colorectal Cancer and Colorectal Cancer Screening, has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 2,404 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.
Conditions Studied
Interventions
- DEVICE Cologuard
Study Locations (20)
California
- Cassidy Medical Group/Radiant Research, Inc. - Carlsbad
- Kindred Medical Institute for Clinical Trials, LLC - Corona
- Paragon Rx Clinical - Garden Grove
- UCLA, Division of Digestive Diseases - Los Angeles
- FACEY Medical Foundation - Mission Hills
- John D. Homan, MD - Newport Beach
- Diverse Research Solutions - Oxnard
- Ventura County Gastroenterology - Oxnard
- Desert Oasis Healthcare Medical Group - Palm Springs
- Advanced Pain Diagnostics & Solutions - Sacramento
Florida
- Innovative Research of West Florida - Clearwater
- Homestead Medical Research - Homestead
- Health Awareness, Inc - Jupiter
- Precision Clinical Research - Lauderdale Lakes
- Advanced Bioresearch - Miami
- Next Phase Research Alliance - Miami
- Clinical Research Center of Florida - Pompano Beach
Arizona
- Thomas C Lenzmeier, M.D., P.C - Glendale
- Central Arizona Medical Associates, PC - Mesa
- Fiel Family and Sports Medicine - Tempe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,404 participants |
| Start Date | 2015-04 |
| Est. Completion | 2020-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02419716
The ClinicalTrials.gov registry entry for NCT02419716 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,404 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,505-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (60% higher). The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cologuard is the first listed.
NCT02419716 reports 20 study locations spanning 3 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT02419716 about?
NCT02419716 is a clinical study titled "A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval". This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.
What is the current status of trial NCT02419716?
This trial is currently completed. The enrollment target is 2,404 participants. The study started on 2015-04. Estimated completion is 2020-03-16.
What conditions does trial NCT02419716 study?
This clinical trial studies the following conditions: Colorectal Cancer, Colorectal Cancer Screening.
What interventions are being tested in trial NCT02419716?
The interventions under investigation include: Cologuard (DEVICE).
Who is sponsoring clinical trial NCT02419716?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02419716 being conducted?
This trial has 20 study locations across Arizona, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.